The purpose of this study is to provide data on the safety and efficacy of pegfilgrastim when administered on the same day versus the next day of chemotherapy, as measured by the duration of grade 4 neutropenia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Neutropenia
Neutropenia
Disease Response
Adverse Events
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.